SUV39H1 disruption enhances the persistence and anti-tumor efficacy of CD28-costimulated human CAR T cells.

被引：0
|
作者：
Jain, Nayan [1 ]
Zhao, Zeguo [1 ]
Koche, Richard [1 ]
Gozlan, Yosi [2 ]
Brocks, David [2 ]
Raveh-Sadka, Tali [2 ]
Wells, Danny [3 ]
Dobrin, Anton [1 ]
Shi, Yuzhe [1 ]
Lopez, Michael [1 ]
Gunset, Gertrude [1 ]
Sadelain, Michel [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, New York, NY USA
[2] Immunai, Tel Aviv, Israel
[3] Immunai, San Francisco, CA USA
来源：
CANCER RESEARCH | 2022年 / 82卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5583
引用
收藏
页数：1
相关论文
共 50 条
  • [21] CRISPR-mediated PTPN2 deletion in CAR T cells enhances anti-tumor efficacy
    Du, Xin
    Wiede, Florian
    Darcy, Phillip K.
    Tiganis, Tony
    CANCER IMMUNOLOGY RESEARCH, 2022, 10 (01)
  • [22] CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
    Levi J. Rupp
    Kathrin Schumann
    Kole T. Roybal
    Rachel E. Gate
    Chun J. Ye
    Wendell A. Lim
    Alexander Marson
    Scientific Reports, 7
  • [23] CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
    Rupp, Levi J.
    Schumann, Kathrin
    Roybal, Kole T.
    Gate, Rachel E.
    Ye, Chun J.
    Lim, Wendell A.
    Marson, Alexander
    SCIENTIFIC REPORTS, 2017, 7
  • [24] Constitutive Expression of CD40L by CAR-Modified Tumor Targeted T Cells Enhances Anti-Tumor Efficacy Both in Vitro and in Vivo
    Curran, Kevin J.
    Seinstra, Beatrijs
    Nikhamin, Yan
    Yeh, Raymond
    Usachenko, Yelena
    Brentjens, Renier J.
    BLOOD, 2012, 120 (21)
  • [25] RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1
    Ming Zhao
    Xiaoyan Wu
    Qing Zhang
    Shuangyan Luo
    Gongping Liang
    Yuwen Su
    Yixin Tan
    Qianjin Lu
    Arthritis Research & Therapy, 12
  • [26] RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1
    Zhao, Ming
    Wu, Xiaoyan
    Zhang, Qing
    Luo, Shuangyan
    Liang, Gongping
    Su, Yuwen
    Tan, Yixin
    Lu, Qianjin
    ARTHRITIS RESEARCH & THERAPY, 2010, 12 (06)
  • [27] Oncolytic Adenovirus Expressing Cytokines Enhances Anti-Tumor Efficacy of Mesothelin-Redirected CAR-T Cells
    Watanabe, Keisuke
    Guedan, Sonia
    Scholler, John
    McGettigan, Shannon
    Luo, Yangpin
    Tahtinen, Siri
    Parviainen, Suvi
    Havunen, Riikka
    Siurala, Mikko
    Hemminki, Akseli
    June, Carl H.
    BLOOD, 2016, 128 (22)
  • [28] COMBINING CD28 AND 4-1BB COSTIMULATION IN TRANS ENHANCES THE ANTI-GLIOMA EFFICACY AND PERSISTENCE OF B7-H3 CAR T CELLS IN IMMUNE-COMPETENT BRAIN TUMOR MODELS
    Haydar, Dalia
    Elayan, Abdul
    Yi, Zhongzhen
    Gottschalk, Stephen
    DeRenzo, Chris
    Krenciute, Giedre
    NEURO-ONCOLOGY, 2022, 24 : 80 - 81
  • [29] Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
    Jian Chen
    Tianchuan Zhu
    Guanmin Jiang
    Qi Zeng
    Zhijian Li
    Xi Huang
    Molecular Cancer, 22
  • [30] Target delivery of a PD-1-TREM2 scFv by CAR-T cells enhances anti-tumor efficacy in colorectal cancer
    Chen, Jian
    Zhu, Tianchuan
    Jiang, Guanmin
    Zeng, Qi
    Li, Zhijian
    Huang, Xi
    MOLECULAR CANCER, 2023, 22 (01)
12345